H Lundbeck (HLUKF) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 8 78 sessions, January 4, 2022 to June 8, 2022
- Largest daily move
- +8.1% close of February 16, 2022
- 1-month change
- +12.2% closing prices, May 6, 2022 to June 8, 2022
Company Description
H Lundbeck (OTC: HLUKF) is classified in the drug manufacturers—specialty & generic industry within the Healthcare sector and carries a market capitalization of $4.9B.
HLUKF has gained 12.2% over the past month. The last closing price was $24.63.
This page collects what Stock Titan holds for HLUKF, including price data.
Stock Performance
H Lundbeck (HLUKF) closed at $24.63 on June 8, 2022. Over the past month, the price has gained 12.2%.
HLUKF Metrics & Rankings
Price returns through June 8, 2022. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
HLUKF Company Profile & Sector Positioning
H Lundbeck (HLUKF) operates in the Drug Manufacturers—Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing HLUKF often look at related companies in the same sector, including Alkermes Inc. plc (ALKS), EMBCV (EMBCV), Plus Prods Inc (PLPRF), Lantheus Holdings, Inc (LNTH), and Regencell Bioscience Holdings Limited (RGC). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate HLUKF's relative position within its industry.